BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
30632186
Number of visits today
1379
Number of downloads
13060174
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yuan Y, Qi G, Shen H, Guo A, Cao F, Zhu Y, Xiao C, Chang W, Zheng S. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. Int J Cancer 2019;144:1584-95. [PMID: 29987896 DOI: 10.1002/ijc.31736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu DJ, Shi WJ, Yu M, Zhang L. High WDR34 mRNA expression as a potential prognostic biomarker in patients with breast cancer as determined by integrated bioinformatics analysis. Oncol Lett 2019;18:3177-87. [PMID: 31452794 DOI: 10.3892/ol.2019.10634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Hao XY, Li AQ, Shi H, Guo TK, Shen YF, Deng Y, Wang LT, Wang T, Cai H. A novel DNA methylation-based model that effectively predicts prognosis in hepatocellular carcinoma. Biosci Rep 2021;41:BSR20203945. [PMID: 33634306 DOI: 10.1042/BSR20203945] [Reference Citation Analysis]
3 Li JL, Chen C, Chen W, Zhao LF, Xu XK, Li Y, Yuan HY, Lin JR, Pan JP, Jin BL, Li FC. Integrative genomic analyses identify WDR12 as a novel oncogene involved in glioblastoma. J Cell Physiol 2020;235:7344-55. [PMID: 32180229 DOI: 10.1002/jcp.29635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li Y, Yuan Y, Zhang F, Guo A, Cao F, Song M, Fu Y, Xu X, Shen H, Zheng S, Pan Y, Chang W. Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma. Front Pharmacol 2021;12:739501. [PMID: 34790119 DOI: 10.3389/fphar.2021.739501] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345